Prof. Dr. med. Mathias
Back to Frontpage
Mathias Freund has been born in 1949 in northern Germany. He has
graduated in medicine at the Eberhard-Karls-University in Tuebingen,
Germany in 1974. He has obtained his physician's license,
doctorate and his licence as a specialist of Internal Medicine and
Hematology/Oncology at the same institution. His research activities in
Tuebingen have been focussed on disseminated intravascular coagulation
and shock lung, breast cancer, leukemias and non-Hodgkin's lymphomas.
He 1982 moved
to the Department of Hematology and Oncology at
Hannover Medical School. Clinical activities concentrated there on
high-grade and low-grade malignant non-Hodgkin's lymphomas, on chronic
and acute leukemias. Besides chemotherapeutic approaches a special
interest was in the basic and clinical effects of cytokines. Prof.
Freund subsequently chaired the Laboratory of Experimental Hematology
there. Activities focussed on cell biologic aspects of the growth and
differentiation of acute and chronic leukemias and stem cell biology.
Clinical and basic developments have been documented in a series of
International Symposia on Cytokines in Hematology, Oncology and
Immunology in Hannover in 1989, 1991, and 1993. Prof. Freund has been
secretary of the annual meeting of the German Society of Hematology and
Oncology in Hannover 1989.
ESMO European Certificate in Medical Oncology.
In October 1994 Prof.
Freund became appointed as chairman of the Department of Hematology and
Oncology at Rostock University. The development of the department
concentrates on high-dose chemotherapy of hematopoietic neoplasias and
solid tumors, bone marrow and blood stem cell transplantation and
chronic GvHD. Recently the department is involved in stem cell therapy
for myocardial and vascular regeneration.
Prof. Freund has been licensed as a specialist in Hemostaseology and in
Palliative Medicine in 2008.
The following business
companies have been established in the surrounding von the Department
of Hematology and Oncology which is chaired by Prof.
Medical Development GmbH Rostock
Stammzelltechnologie GmbH (former Gesellschaft für
Stammzelltechnologie Rostock GmbH) and Seracell Pharma AG
in Immunology GmbH Rostock
für Integrative Medizin an der Universität Rostock gGmbH i.G.
Prof. Freund holds equities in these companies directly and indirectly
Secretary and Treasurer of the German Society of Hematology and
Oncology since 1996, President of the Annual Meeting of the German,
Swiss Societies of Hematology and Oncology in 2005, President of the
Cancer Society of Mecklenburg-Vorpommern, Chairman of the Tumor Center
of Rostock and Member in numerous scientific societies. He is President
of the Board of Directors of the Seracell AG.
published 291 journal articles, 24 books, 88 book chapters and 678
Design Copyright by:
M.D. Medical Development GmbH, POB 10 50 40, D-18010 Rostock, Germany